Overview

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)

Status:
Completed
Trial end date:
2006-02-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness of a marketed drug in the treatment of a menstrual migraine attack.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Rizatriptan